Table 2.
Comparison of body composition parameters determined with bioelectrical impedance-based methods.
| All Patients (n = 123) |
Study 1 (n = 67) | Study 2 (n = 44) | Study 3 (n = 12) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TANITA | BIACORPUS | p-Value | TANITA | BIACORPUS | p-Value | TANITA | BIACORPUS | p-Value | TANITA | BIACORPUS | p-Value | |
| BFP (%) | 41.4 ± 7.8 | 39.1 ± 6.7 | 0.000 | 41.6 ± 8.1 | 39.4 ± 6.8 | 0.000 | 40.7 ± 7.7 | 37.9 ± 6.0 | 0.000 | 43.0 ± 7.0 | 42.1 ± 8.2 | 0.481 |
| FM (kg) | 41.6 ± 17.8 | 38.6 ± 14.3 | 0.000 | 41.8 ± 18.5 | 39.0 ± 14.6 | 0.000 | 39.3 ± 17.4 | 36.3 ± 13.8 | 0.001 | 48.6 ± 14.5 | 45.2 ± 12.7 | 0.252 |
| FFM (kg) | 56.2 ± 14.2 | 58.9 ± 16.2 | 0.000 | 56.2 ± 14.3 | 59.1 ± 16.9 | 0.000 | 54.7 ± 13.6 | 57.7 ± 15.4 | 0.001 | 61.3 ± 15.9 | 62.1 ± 15.6 | 0.520 |
Results are presented as mean ± SD; comparison of the body composition methods was made using paired samples t-test; BFP body fat percentage, FM fat mass, FFM fat free mass. TANITA (Type BC-418MA, TANITA Corporation, Tokyo, Japan), BIACORPUS (BIACORPUS RX 4000, Medical Healthcare GmbH, Karlsruhe, Germany).